Jonathan Golledge1, Paul E Norman. 1. The Vascular Biology Unit, School of Medicine, James Cook University, Townsville, Australia. Jonathan.Golledge@jcu.edu.au
Abstract
PURPOSE OF REVIEW: Abdominal aortic aneurysm (AAA) is being diagnosed more frequently in older patients due to the increased use of abdominal imaging and the rising average age of western populations. Currently the management of this condition has two important deficiencies: inadequate methods to identify AAAs at risk of progression and rupture and the current lack of effective nonsurgical therapies. In this review recent developments in identifying new diagnostic, prognostic and therapeutic strategies for AAA are discussed. RECENT FINDINGS: There are growing number of animal and human association studies which have identified markers and strategies of potential value in improving identification, monitoring and treatment of AAA. SUMMARY: Selective large prospective imaging, biomarker and intervention studies are now required to clearly demonstrate the value of new management pathways for AAA.
PURPOSE OF REVIEW: Abdominal aortic aneurysm (AAA) is being diagnosed more frequently in older patients due to the increased use of abdominal imaging and the rising average age of western populations. Currently the management of this condition has two important deficiencies: inadequate methods to identify AAAs at risk of progression and rupture and the current lack of effective nonsurgical therapies. In this review recent developments in identifying new diagnostic, prognostic and therapeutic strategies for AAA are discussed. RECENT FINDINGS: There are growing number of animal and human association studies which have identified markers and strategies of potential value in improving identification, monitoring and treatment of AAA. SUMMARY: Selective large prospective imaging, biomarker and intervention studies are now required to clearly demonstrate the value of new management pathways for AAA.
Authors: Albert Busch; Caroline Grimm; Elena Hartmann; Valentina Paloschi; Ralph Kickuth; Mariette Lengquist; Christoph Otto; Per Eriksson; Richard Kellersmann; Udo Lorenz; Lars Maegdefessel Journal: Histochem Cell Biol Date: 2017-05-06 Impact factor: 4.304
Authors: Joseph V Moxon; Adam Parr; Theophilus I Emeto; Philip Walker; Paul E Norman; Jonathan Golledge Journal: Curr Probl Cardiol Date: 2010-10 Impact factor: 5.200
Authors: Sophie E Rowbotham; Jenna L Pinchbeck; Georgina Anderson; Bernie Bourke; Michael Bourke; T Christian Gasser; Rene Jaeggi; Jason S Jenkins; Corey S Moran; Susan K Morton; Christopher M Reid; Ramesh Velu; Lisan Yip; Joseph V Moxon; Jonathan Golledge Journal: Trials Date: 2017-11-16 Impact factor: 2.279
Authors: Theophilus I Emeto; Faith O Alele; Amy M Smith; Felicity M Smith; Tammy Dougan; Jonathan Golledge Journal: Front Cardiovasc Med Date: 2017-03-23
Authors: Jonathan Golledge; Graeme J Hankey; Bu B Yeap; Osvaldo P Almeida; Leon Flicker; Paul E Norman Journal: PLoS One Date: 2014-07-18 Impact factor: 3.240